Skip to main content
. 2022 Feb 14;40(13):2062–2067. doi: 10.1016/j.vaccine.2022.02.025

Table 2.

Geometric mean titers by adverse reaction variables for each dose.

Dose 1
Dose 2
No. (%) GMT (95 %CI) p-value No. (%) GMT (95 %CI) p-value
Use of antipyretic Medications
Use of Antipyretic Medications after Vaccination No 293 (87.5) 8,922 (8,243–9,658) 0.373a 191 (57.0) 8,163 (7,384–9,026) 0.017a
Yes 42 (12.5) 8,084 (6,574–9,940) 144 (43.0) 9,757 (8,766–10,857)
Local Reactions
Pain at inInjection site No 116 (49.4) 8,728 (7,674–9,924) 0.400a 131 (55.7) 8,993 (7,998–10,113) 0.840a
Yes 119 (50.6) 9,406 (8,343–10,605) 104 (44.3) 9,154 (8,015–10,457)
Redness No 233 (99.2) 9,014 (8,257–9,840) 0.318a 222 (94.5) 9,034 (8,243–9,901) 0.763a
Yes 2 (0.9) 17,742 (161–811,757) 13 (5.5) 9,581 (7,470–12,286)
Swelling No 225 (95.7) 9,135 (8,362–9,979) 0.517a 218 (92.8) 9,009 (8,226–9,867) 0.630a
Yes 10 (4.3) 7,612 (4,154–13,944) 17 (7.2) 9,797 (6,914–13,880)
Itching No 228 (97.0) 9,061 (8,291–9904) 0.966a 224 (95.3) 9,122 (8,333–9,984) 0.437a
Yes 7 (3.0) 9,166 (4,192–17,108) 11 (4.7) 7,974 (5,573–11,408)
Systemic Reactions
Fever <37.0 °C 218 (92.8) 9,137 (8,356–9,990) 0.290b 93 (39.6) 7,186 (6,314–8,180) <0.001b
37.0–37.9 °C 15 (6.4) 8,927 (5,617–14,188) 91 (38.7) 9,374 (8,152–10,781)
≥38 °C 2 (0.9) 4,276 (597–30,620) 51 (21.7) 13,035 (10,943–15,528)
Fatigue No 205 (87.2) 8,972 (8,190–9,829) 0.603a 108 (46.0) 7,947 (6,992–9,030) 0.006a
Yes 30 (12.8) 9,723 (7,211–13,111) 127 (54.0) 10,139 (9,014–11,402)
Headache No 215 (91.5) 8,920 (8,145–9,772) 0.260a 153 (65.1) 8,404 (7,523–9,386) 0.017a
Yes 20 (8.5) 10,750 (7,781–14,853) 82 (34.9) 10,440 (9,082–12,001)
Chills No 229 (97.5) 9,126 (8,366–9,959) 0.557a 159 (67.7) 8,045 (7,229–8,952) <0.001a
Yes 6 (2.6) 6,964 (2,313–20,970) 76 (32.3) 11,633 (10,127–13,366)
Nausea No 230 (97.9) 9,061 (8,295–9,899) 0.963a 217 (92.3) 8,925 (8,147–9,777) 0.218a
Yes 5 (2.1) 9,204 (3,796–22,325) 18 (7.7) 10,922 (7,930–15,038)
Diarrhea No 229 (97.5) 9,020 (8,255–9,854) 0.536a 220 (93.6) 9,059(8,274–9,922) 0.964a
Yes 6 (2.6) 10,967 (5,178–23,233) 15 (6.4) 9,131 (6,396–13,038)
Muscle Pain No 188 (80.0) 8,847 (8,000–9,784) 0.229a 168 (71.5) 8,668 (7,805–9,625) 0.103a
Yes 47 (20.0) 9,988 (8,398–11,877) 67 (28.5) 10,141 (8,654–11,865)
Joint Pain No 223 (94.9) 9,166 (8,397–10,007) 0.430a 176 (74.9) 8,720 (7,872–9,661) 0.122a
Yes 12 (5.1) 7,364 (4,117–13,170) 59 (25.1) 10,174 (8,596–12,041)
Rash No 231 (98.3) 9,152 (8,379–9,995) 0.011a 231 (98.3) 9,074 (8,306–9,911) 0.875a
Yes 4 (1.7) 5,207 (3,582–7,570) 4 (1.7) 8,549 (2,842–25,704)

a: t-test.

b: ANOVA.

GMT, geometric mean titer.